AKT1 and neoplasm: Transcriptomic analysis and in vivo mouse experiments confirmed that compound I-27 inhibits tumor angiogenesis and induces TNBC cell apoptosis via the ID1/TSP-1 and PI3K/AKT/FoxO1 signaling pathways.